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Context: Apparently healthy blood donors might carry out 
transfusion transmitted infections which might be fatal for the 
donor himself as well as the recipient later on. 
Aim: To assess the seroprevalence of transfusion-transmitted 
infections (TTI) among apparently healthy blood donors in 
Ranchi, India.  
Methods and Materials: All blood samples were screened for 
HIV-I and II, HBsAg, HCV (by using third generation enzyme-
linked immunoadsorbent assay technique), Syphilis (by Rapid 
Plasma Reagin Kit), and Malaria antigen both for plasmodium  
falciparum and plasmodium vivax (by One step, rapid, 
immunochromatographic test). 
Result: On screening of 106,306 blood units for TTIs, 1,462 
(1.37 %) donors were found positive for one of the TTIs. Highest 
prevalence was for HBV (970 donors - 0.91%) ranging from 
0.73% to 1.19%. This was followed by Malaria (272 donors - 
0.25%) ranging from 0.08% to 0.48%, HCV (127 donors - 0.11%) 
ranging from 0.04% to 0.25%, HIV (72 donors - 0.06%) ranging 
from 0.03% to 0.10%, and syphilis (21 donors 0.01%) ranging 
from 0.00% to 0.09%. 
Conclusions: Apparently healthy blood donors are not omitted 
from the danger of transfusion-transmitted infection. 
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Introduction 
 
The goal of any transfusion service is to provide adequate and safe blood and 
blood products to the recipients. With every unit of blood transfusion, there is a 
1% chance of transfusion related complications including transfusion-transmitted 
infections [1]. The process of preventing the transmission of transfusion-
transmitted infections through blood transfusion presents one of the greatest 
challenges of transfusion medicine [2]. The Drug and Cosmetic Act, 1945 and its 
amendments require that all blood donations must be screened against the five 
major infections: HIV I & II, HBsAg, HCV, syphilis, and malaria [3][4]. 
Consequently, NACO recommended 3rd or 4th generation ELISA HIV I & II test 
kits with high sensitivity as the default test for use at blood banks for screening 
donated blood [5]. Blood transfusion departments not only screen TTI, but they 
also provide information about the prevalence of these infections in populations 
[6]. Blood safety interventions in the developed nations have greatly reduced the 
overall risk of transfusion-transmitted infections [7]. Globally, more than 81 
million units of blood are donated each year [8]. More than 18 million units of 
blood are not screened for transfusion transmissible infections [9]. They are, 
therefore, unlikely to be totally free of the risk of the infections. The aim of our 
study is to investigate the prevalence of transfusion transmitted infections among 
apparently healthy donors in Ranchi, India, and to raise the awareness of 
infectious complications of blood transfusion 
 
 
Materials and Methods 
 
The present retrospective study was carried out at blood bank of tertiary 
care hospital, Rajendra Institute of Medical Sciences (RIMS), Ranchi, India from 
January 2008 to December 2014. The blood collections were carried out from the 
voluntary donors at outdoor blood donation camp and in-house blood bank as 
well as from replacement donors at blood bank. Physical examination and 
answers of donor’s questionnaire were carefully screened by trained personnel. 
From the donor’s blood unit, 5 mL blood samples were obtained for serological 
testing both in plain and EDTA vials at the time of bleeding. Blood samples were 
screened for hepatitis B surface antigen (HBsAG) by SD HBsAg Kit (Bio 
Standard Diagnostic), hepatitis C virus (HCV) antibodies by SD HCV Kit (Bio 
Standard Diagnostic), and human immunodeficiency virus (HIV-1 & HIV-2) 
antibodies by Span HIV kit (Span Diagnostic). These were third generation 
enzyme-linked immunoadsorbent assay technique. Syphilis was tested by RPR-
Rapid Plasma Reagin Kit (modified slide test, Pathozyme Diagnostic) and 
Malaria was screened by SD Malaria Kit (One step, rapid, 
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immunochromatographic test for detection of plasmodium falciparum and 
plasmodium vivax antigen - Bio Standard Diagnostic).  
 
 
Result 
 
A total of 106,306 blood units (Voluntary and replacement) were received 
into our blood bank from January 2008 to December 2014 (Table 1). After the 
screening of the 106,306 blood units for TTIs, 1,462 (1.37 %) donors were found 
positive for one of the TTIs. Highest prevalence was for HBV (970 donors - 
0.91%) ranging from 0.73% to 1.19%. This was followed by Malaria (272 donors - 
0.25%) ranging from 0.08% to 0.48%, HCV (127 donors - 0.11%) ranging from 
0.04% to 0.25%, HIV (72 donors -0.06%) ranging from 0.03% to 0.10%, and 
syphilis (21 donors 0.01%) ranging from 0.00% to 0.09 (Table 2 and Table 3). 
 
Table 1. Total No of Blood Units Collection, Year Wise from 2008-2014. (Age of 
Donors, 18-60 Years) 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Percentage of Transfusion Transmitted Infections among Blood Donors, Year wise (2008-2014) 
S.N 
Name 
of the 
year 
Total no                   
of HIV 
positive 
cases 
% of 
HIV 
positive 
cases 
Total no 
of  
HBSAg 
positive 
cases 
%  of 
HBSAg 
positive 
cases 
Total no 
of HCV 
positive 
cases 
% of 
HCV 
positive 
cases 
Total no of 
Malarial 
Parasite 
Positive 
cases 
% of 
Malarial 
Parasite 
positive 
cases 
Total 
no of  
Syphilis 
positive 
cases 
% of 
Syphilis 
positive 
cases 
1 2008 04 0.03 110 0.94 14 0.11 50 0.42 03 0.02 
2 2009 04 0.03 133 1.19 05 0.04 09 0.08 Nil 0.00 
3 2010 12 0.10 95 0.80 12 0.10 23 0.19 Nil 0.00 
4 2011 11 0.08 127 0.96 34 0.25 64 0.48 12 0.09 
5 2012 14 0.08 166 0.99 17 0.10 66 0.39 05 0.02 
6 2013 15 0.07 151 0.73 26 0.12 34 0.16 01 0.0048 
7 2014 12 0.05 188 0.88 19 0.08 26 0.12 Nil 0.00 
 
 
 
 
 
 
S.N 
 
Name of the year 
 
No of collection 
1 2008 11,685 
2 2009 11,085 
3 2010 11,805 
4 2011 13,224 
5 2012 16,767 
6 2013 20,507 
7 2014 21,233 
 Grand Total 106,306 
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Table 3. Average Percentage of Transfusion Transmitted Infections among 
Blood Donors from 2008-2014 
S.N 
Total 
collection of 
blood units 
during 2008 
to 2014 
Transfusion 
transmitted 
infections 
Total no of 
positive cases 
during 2008 to 
2013 
Average % of 
positive cases 
during 2008 to 
2013 
1 
106,306 
HIV 72 0.06 
2 HBSAg 970 0.91 
3 HCV 127 0.11 
4 Malarial Parasite 272 0.25 
5 Syphilis 21 0.01 
  Grand Total 1,462 1.37 
 
 
Discussion  
 
The main blood borne viruses ‘viz. hepatitis B virus (HBV), human 
immunodeficiency virus (HIV), and hepatitis C virus (HCV), are a major public 
health issue. Therefore, they represent the significant causes of morbidity and 
mortality which are associated with transfusion. Prevalence of Malaria is still 
higher in Jharkhand region ranging from 0.08-0.48%. This would, however, result 
to the wastage of many blood units every year. Most of the problems arise due to 
the prevalence of asymptomatic carriers in the society, as well as blood donations 
during the window period of infections [10].  The study of Gupta et al. states that 
accurate estimates of the risk of TTIs are essential for monitoring the safety of 
blood supply and in evaluating the efficacy of the currently employed screening 
procedures [11]. The prevalence of TTIs among blood donors in well-structured 
health care system with a well-organized blood establishment can be used as a 
reliable tool for statistical estimations of those infectious agents that can be 
transmitted through blood products; also, it can contribute to statistical 
estimation of these viruses in the general population as discussed by 
Gharehbaghian [12]. Khedmat et al. reported the results of serological screening 
tests for HBV, HCV, HIV, and syphilis infections in Iran performed by Tehran 
blood transfusion service between 2003 and 2005 in 1,004,889 subjects [13]. The 
result showed that the seroprevalence was 0.9% for HBsAg, 2.1% for anti-HCV, 
0.2% for HIV Antibody 1 and 2, and 0.04% for VDRL [13]. Between 2003 and 
2005, a decreasing trend was observed in the frequency of HbsAg as discussed by 
Khedmat et al. [13]. Jeremiah et al. reported HCV prevalence rates of 5.0% 
among donors in Port Harcourt, Nigeria [14]. Chandra et al. reported prevalence 
rates of replacement and voluntary donors for HIV (0.08 - 0.15%), HBV (0.24 - 
1.67%), HCV (0.001 - 0.49%), VDRL (0.008 - 0.01%), and malaria (0.009–0.01%) 
in their study [10].  When compared to the study of Chandra et al., our study 
showed low prevalence rates of replacement and voluntary donors for HIV (0.03% 
to 0.10%), HBV (0.73 - 1.19%), and HCV (0.04% to 0.25%); on the other hand, it 
shows very high prevalence rate for malaria (0.08% to 0.48%) [10]. 
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The reason for the high prevalence of malaria in Ranchi location is as a result 
of its geographically endemic zone for malarial parasite. Mollison et al. reported 
that the rate of transfusion transmitted malaria varies from less than 0.2 in 
nonendemic countries to 50 or more cases per million in endemic countries [15]. A 
study conducted at Agha Khan University Hospital showed that the rate of 
seropositivity of syphilis does not seem to be changing during the past several 
years. Thus, this is with an annual rate of less than 1%, which is similar with our 
study. Out of the 114,122 samples tested during the period mentioned, 252 donors 
were positive for syphilis antibodies which make an overall prevalence of 0.22% as 
discussed by Moiz et al. [16]. Blood Transfusion Center Nishtar Hospital Multan 
and Fatimid Blood Transfusion Center Multan tested for HbsAg, anti-HCV and 
HIV; and they noted that the prevalence of hepatitis B and C and HIV infection 
was 3.37%, 0.27%, and 0%, respectively, “as discussed by Mahmood et al. [17].” 
Furthermore, Chandra et al. reported that seropositivity was low both for 
Malaria (0.009%) and syphilis (0.01%) [10][18]. Seropositivity of VDRL infection 
has been constant (0.01%) in the last 12 years from 2001 - 2012. The data which 
provides a picture of TTI burden in India has come from various seroprevalence 
studies (Table 4 and Table 5) as shown by the studies of Pallavi et al. and Dogra 
et al. [19][37]. 
 
Table 4. Comparison of TTI prevalence rate in different parts of India [19] 
Place HIV (%) HbsAg (%) HCV (%) Syphilis (%) 
Delhi 0.56 2.23 0.66  
Southern Haryana 0.3 1.7 1.0 0.9 
West Bengal 0.28 1.46 0.31 0.72 
Bangalore, Karnataka 0.44 1.86 1.02 1.6 
Mysore 0.44 1.27 0.23 0.28 
Present study 0.06 0.91 0.11 0.01 
 
Table 5. Comparison of prevalence of TTIs with various studies in India [36][37] 
Author & Year Place Total TTIs HIV HBV HCV Syphilis 
Gupta N et al 
(2001-2003) Ludhiana 2.68 % 0.084 % 0.66 % 1.09 % 0.85% 
Chadra et al 
(2001–2006) Lucknow, U.P. 2.54 % 0.23 % 1.96 % 0.34 %  0.01% 
Nilima Sawke et a 
(2006–2008) Bhanpur, M.P. 4.21 % 0.51 % 2.90 % 0.57 % 0.23% 
Bhawani et al 
(2004-2009) Vikarabad, AP 2.72 % 0.39 % 1.41 % 0.84 % 0.08 % 
Jasani et al 
(2004-2011) 
PIpARIA 
Piparia, Gujarat 3.35 % 0.25 % 1.35 % 0.85 % 0.90 % 
Dayal S 
2006-2011 Etawah, UP 3.16 % 0.19 % 2.63 % 0.34 % not done 
Patel. A.et al 
(2005-2011) 
Sola, Ahmedabad, 
Gujarat 0.53 % 0.08 % 0.30 % 0.09 % 0.06 % 
Dogra Shruti et al 
(2009-2012) New Delhi 4.3 % 0.72 % 2.4 % 0.7 % 0.48 % 
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Present study 
(2008-2014) Ranchi, Jharkhand 1.37 % 0.06 % 0.91 % 0.11 % 0.01 % 
 
For HIV, India is second only to South Africa in terms of the overall number 
of people living with HIV [19].  The Indian National AIDS Control Organization 
(NACO) suggested an overall prevalence of 0.91% (2005) in India with 0.25% in 
Delhi [21]. The prevalence of HIV in various parts of India is different with high 
rate in the western and southern parts [22]. Western India has reported an HIV 
seroprevalence of 0.47%, while that in Punjab is 0.26% [23][24]. Sonwane et al. 
have reported a prevalence of 1.83% in the rural population [20]. The present 
study showed a HIV prevalence of 0.06%, while Srikrishna et al. have noted 
0.44%, Pahuja et al. have noted 0.56, and Singh et al. have noted 0.54% of HIV 
seroprevalence [2][21][22]. A WHO report states that the viral dose in HIV 
transmission through blood is so large that one HIV positive transfusion leads to 
death, on an average, after 2 years in children and after 3 to 5 years in adults 
[25]. Hence, safe transfusion practices like avoidance of single donors and 
practices of autologous blood transfusion should be encouraged [26]. 
India has been placed in the intermediate zone of the prevalence of hepatitis 
B by the World Health Organization (2 - 7% prevalence rates) [21]. Lodha et al. 
reported HbsAg prevalence rate of 1–2% in India [27]. Supporting this, HbsAg 
prevalence in Punjab blood donors was 1.7%, while Rajasthan had 3.44%, and 
Delhi had 2.23% [2][28][21]. In Karnataka, coastal area had 0.62% and Bangalore 
had 1.86% of HBV seropositivity [29][2]. Singh et al. have reported a HbsAg 
prevalence of 1.8%, whereas Joshi and Ghimere have reported a prevalence of 
2.71% in healthy Nepalese males [21][22]. Prevalence of HbsAg in our blood 
donors was 0.77%. On the other hand, the prevalence of HBV infection is lower 
in the United States and Western Europe (0.1–0.5%), and is reported to be 
higher, 5–15% in South East Asia and China [21]. Bhattacharya explored a high 
rate of occult HBV infection prevalence among HbsAg negative/anti-HBC 
positive donors and, thus, emphasized the need for a more sensitive and stringent 
screening algorithm for blood donations [30]. Gupta et al. have also found more 
anti HCV positivity than HbsAg, suggesting the ability to detect hepatitis B 
virus (HBV) infection in window period [31]. India is still in the intermediate 
prevalence zone for HbsAg and has been estimated to be a home to over 40 
million HbsAg carriers. Despite the fact that a safe and effective vaccine has been 
available since 1982, the HbsAg prevalence in India still remains high. This is 
because hepatitis B vaccination is not a part of our national immunization 
programme [21]. The wide variations of HCV seroprevalance in different studies 
in India might be due to the use of different generation of ELISA test kits, 
having different sensitivities and specificities [21]. Among the studies done, Garg 
et al. have reported an HCV prevalence of 0.28% in blood donors of Western 
India, and low prevalence of 0.11 % has been noted in our study [32]. Sri Krishna 
et al. have noted a prevalence of 1.02%, while Sood et al. and Pahuja et al. have 
reported a high prevalence of 2.2 and 2.23% in Delhi, respectively [2][21]. In 
addition to this, HCV prevalence by Kaur et al. was 0.78%, Singh et al. was 
0.5%, and Jain et al. was 1.57% in New Delhi voluntary blood donors [24][21]. 
Internationally, various studies have reported an HCV prevalence range of 0.42–
1.2% [21]. 
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Sexually transmitted infections are widespread in developing countries, and it 
constitutes a major public health problem. The VDRL reactivity in our study was 
0.01%. A comparatively very low value when compared to 1.6% was noted by 
SriKrishna et al. [2]. Also, 2.6% was recorded by Singh et al. [22] in Delhi. Arora 
et al. have reported a 0.9% of VDRL reactivity, while Bhattacharya found 0.72% 
reactivity [25][30]. Syphilis has also acquired a new potential for morbidity and 
mortality through association with increased risk of HIV infection, thus making 
safe blood more difficult to get. In studies related to this, Gupta et al., Otuonye 
et al., and Patil et al. observed a definite correlation between the positivity of 
HIV and syphilis [31][33][34]. Therefore, serological screening for syphilis serves as 
a surrogate test for HIV infected donors. Our study noted no correlation between 
HIV and other infections. A strict selection criteria for blood donors to exclude 
those with multiple sexual partners is recommended, and all the affected donors 
should be treated appropriately [35]. 
 
 
Conclusion      
 
For safe blood transfusion, all blood units should be tested for Transfusion-
transmitted infections with reduction in unnecessary blood transfusion. We have 
low total TTI burden and low prevalence of HIV, HBV, HCV, and Syphilis as 
comparable to other studies done in various parts of India (Table 4 and Table 5). 
This is with high prevalence of malaria as comparable to the study done by 
Chandra et al. that might be possible because Ranchi comes under endemic zone 
for malarial parasite. Implementation of strict donor selection criteria, the use of 
more sensitive screening tests, and the establishment of strict guidelines for blood 
transfusion would possibly help to reduce the incidence of TTI in the Indian 
scenario. 
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